Primary non-response to tumor necrosis factor antagonists is associated with inferior response to second-line biologics in patients with inflammatory bowel diseases: a …
Abstract Background and Aims We sought to analyze whether response to a second-line
biologic varies depending on the reason for discontinuation of the primary anti-TNF agent …
biologic varies depending on the reason for discontinuation of the primary anti-TNF agent …
Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel …
S Singh, J George, BS Boland… - Journal of Crohn's …, 2018 - pubmed.ncbi.nlm.nih.gov
Background and aims We sought to analyze whether response to a second-line biologic
varies depending on the reason for discontinuation of the primary anti-TNF agent (primary …
varies depending on the reason for discontinuation of the primary anti-TNF agent (primary …
[HTML][HTML] Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory …
S Singh, J George, BS Boland… - Journal of Crohn's & …, 2018 - ncbi.nlm.nih.gov
Methods Through a systematic search through May 31, 2017, we identified eight
randomized controlled trials [RCTs] of biologics in patients with IBD with prior exposure to …
randomized controlled trials [RCTs] of biologics in patients with IBD with prior exposure to …
Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel …
S Singh, J George, BS Boland… - Journal of Crohn's …, 2018 - search.ebscohost.com
Abstract Background and Aims: We sought to analyze whether response to a second-line
biologic varies depending on the reason for discontinuation of the primary anti-TNF agent …
biologic varies depending on the reason for discontinuation of the primary anti-TNF agent …
Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel …
S Singh, J George, BS Boland, NV Casteele… - Journal of Crohn's and …, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background and Aims</jats:
title>< jats: p> We sought to analyze whether response to a second-line biologic varies …
title>< jats: p> We sought to analyze whether response to a second-line biologic varies …
Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel …
S Singh, J George, BS Boland… - Journal of Crohn's …, 2018 - academic.oup.com
Abstract Background and Aims We sought to analyze whether response to a second-line
biologic varies depending on the reason for discontinuation of the primary anti-TNF agent …
biologic varies depending on the reason for discontinuation of the primary anti-TNF agent …
Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel …
S Singh, J George, BS Boland, V Casteele… - Journal of Crohn's & …, 2018 - europepmc.org
Methods Through a systematic search through May 31, 2017, we identified eight
randomized controlled trials [RCTs] of biologics in patients with IBD with prior exposure to …
randomized controlled trials [RCTs] of biologics in patients with IBD with prior exposure to …